Recombinant DNA Technology Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 22
SKU : PH2798
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the Recombinant DNA Technology Market?
The Recombinant DNA Technology Market is expected to grow at a CAGR of 4.80% during the forecast period 2024-2031.
Who are the key players in the Recombinant DNA Technology Market?
Key players are F. Hoffmann-La Roche Ltd, Biogen, Amgen Inc, Novartis AG, Eli Lilly and Company, Pfizer Inc., Novo Nordisk A/S, Sanofi, Merck KGaA, GlaxoSmithKline plc., and Thermo Fisher Scientific, Inc.
Related Reports
pharmaceuticalsKrabbe Disease Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 17
Starting from
$4350
pharmaceuticalsCluster Headache Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 03
Starting from
$4350
pharmaceuticalsOral Thin Films Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 22
Starting from
$4350
pharmaceuticalsPsychedelic Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 22
Starting from
$4350
pharmaceuticalsAcute Migraine Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 29
Starting from
$4350
pharmaceuticalsDiabetic Nephropathy Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 19
Starting from
$4350